Adenosine Dose and Cardioversion in Pediatric Supraventricular Tachycardia: A Systematic Review and Meta-Analysis

1

Supraventricular tachycardia (SVT) is the most common arrhythmia in children, with an incidence of 1 in 250 to 1 in 1000.
2

Intravenous adenosine is the first-line treatment for SVT due to its rapid onset and favorable safety profile.
3

There is significant variability in adenosine dosing across clinical settings, indicating uncertainty about optimal dosing for cardioversion.
4

The systematic review aimed to evaluate weight-based adenosine dosing and its success in achieving cardioversion in pediatric patients.
5

Subgroup analyses were conducted to assess cardioversion outcomes based on different weight-based adenosine dose categories.

Pediatric Cardiology

by Laís dos Santos, Thaís Martins Shehan, Candela Lang, Ricardo Sanchez Algarin, Ingrid Bezerra de Oliveira Ribeiro, Paulo Cesar Mattos Dourado de Mesquita, Guilherme Dagostin de Carvalho
June 5, 2026

1